228
Participants
Start Date
May 25, 2018
Primary Completion Date
May 15, 2020
Study Completion Date
May 15, 2020
TEV-50717
6, 9, and 12 mg oral tablets
Placebo
Placebo comparator
Teva Investigational Site 060-0901, Budapest
Teva Investigational Site 060-1403, La Plata
Teva Investigational Site 060-1802, Liverpool
Teva Investigational Site 046-0302, Herlev
Teva Investigational Site 060-2007, Kiev
Teva Investigational Site 060-2005, Kyiv
Teva Investigational Site 046-0301, Odense
Teva Investigational Site 060-1404, Mendoza
Teva Investigational Site 060-1902, Seoul
Teva Investigational Site 060-0902, Szeged
Teva Investigational Site 046-0124, New York
Teva Investigational Site 060-0154, New York
Teva Investigational Site 046-1702, Belgrade
Teva Investigational Site 046-1703, Belgrade
Teva Investigational Site 046-0102, Rochester
Teva Investigational Site 046-1701, Novi Sad
Teva Investigational Site 060-2006, Vinnytsia
Teva Investigational Site 046-0118, Petersburg
Teva Investigational Site 046-0605, Madrid
Teva Investigational Site 046-0602, Madrid
Teva Investigational Site 046-0603, Málaga
Teva Investigational Site 046-0116, Atlanta
Teva Investigational Site 060-1105, Krakow
Teva Investigational Site 060-0160, Gainesville
Teva Investigational Site 046-0115, Orlando
Teva Investigational Site 060-0153, Orlando
Teva Investigational Site 046-0114, St. Petersburg
Teva Investigational Site 046-0104, Dothan
Teva Investigational Site 060-1603, León
Teva Investigational Site 046-0601, Seville
Teva Investigational Site 060-2003, Dnipropetrovsk
Teva Investigational Site 046-0133, Naperville
Teva Investigational Site 060-0155, Chicago
Teva Investigational Site 060-0164, Chicago
Teva Investigational Site 060-2001, Kharkiv
Teva Investigational Site 060-2002, Kharkiv
Teva Investigational Site 060-0170, Bridgeton
Teva Investigational Site 046-0110, Saint Charles
Teva Investigational Site 060-1602, Monterrey
Teva Investigational Site 060-1604, Monterrey
Teva Investigational Site 046-0107, Rogers
Teva Investigational Site 046-0106, Oklahoma City
Teva Investigational Site 046-0113, Dallas
Teva Investigational Site 060-0163, Fort Worth
Teva Investigational Site 046-0108, Houston
Teva Investigational Site 046-0120, San Antonio
Teva Investigational Site 060-1601, Culiacán
Teva Investigational Site 060-1003, Naples
Teva Investigational Site 046-0105, Orem
Teva Investigational Site 046-0111, San Diego
Teva Investigational Site 046-0126, Anaheim
Teva Investigational Site 060-1001, Catania
Teva Investigational Site 046-0101, Sacramento
Teva Investigational Site 046-0703, Voronezh
Teva Investigational Site 046-0704, Tomsk
Teva Investigational Site 060-1504, Pereira
Teva Investigational Site 060-0166, Gulf Breeze
Teva Investigational Site 060-0161, Miami
Teva Investigational Site 046-0128, Boston
Teva Investigational Site 046-0134, Lincoln
Teva Investigational Site 046-0109, Voorhees Township
Teva Investigational Site 060-0169, Charleston
Teva Investigational Site 060-0156, Nashville
Teva Investigational Site 060-0162, Everett
Teva Investigational Site 060-1407, Buenos Aires
Teva Investigational Site 060-1402, Buenos Aires
Teva Investigational Site 046-0201, Ajax
Teva Investigational Site 046-0202, Ottawa
Teva Investigational Site 060-1503, Bello
Teva Investigational Site 060-1005, Cagliari
Teva Investigational Site 060-1104, Gdansk
Teva Investigational Site 060-1101, Katowice
Teva Investigational Site 060-1102, Poznan
Teva Investigational Site 060-1103, Warsaw
Teva Investigational Site 060-1901, Seoul
Teva Investigational Site 060-1903, Seoul
Collaborators (1)
Nuvelution TS Pharma, Inc.
INDUSTRY
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY